Fresenius Medical Care North America

Name

Fresenius Medical Care North America

Legal name

Fresenius Medical Care

Website

https://fmcna.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Dialysis Services & Products

NAICS

Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621), Offices of Physicians (62111)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

akta.pro secondary industries

Outpatient Dialysis & Kidney Care Centers (HLAFABAE), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Home Dialysis Support & Training Providers (HLAFAEAG)

Keywords

• Dialysis services
• Kidney care products
• Renal pharmaceuticals
• Hemodialysis equipment
• Vascular access care

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Dialysis Treatment Services: Revenue from operating dialysis centers providing hemodialysis and peritoneal dialysis treatments to patients with kidney disease. The company operates approximately 3,600 dialysis centers globally.
2. Dialysis Products and Equipment: Sale of dialysis machines, water treatment systems, dialyzers, bloodlines, concentrates, and related disposables to healthcare providers and for use in company-owned centers.
3. Renal Pharmaceuticals: Sale of prescription drugs for kidney disease patients including Venofer (iron) and Velphoro (phosphate binder).
4. Laboratory and Diagnostic Services: Diagnostic testing services for dialysis patients through laboratory services.
5. Renal Pharmacy Services: Specially trained pharmacists providing renal pharmacy services to dialysis patients.
6. Practice Support Services: Services to physician practices including practice management, renal research (Renal Research Institute, Frenova), and apheresis services.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels11 records

Core offering

Fresenius Medical Care North America operates a vertically integrated dialysis business that runs approximately 3,600 dialysis centers providing in-center and home dialysis treatments, vascular access care, laboratory and renal pharmacy services to patients with kidney disease. It also manufactures and sells dialysis machines (5008X CAREsystem, 2008T BlueStar), home peritoneal dialysis systems (Liberty Select Cycler, stay•safe CAPD), water treatment systems, ECMO critical care devices, fluid management monitors, dialyzers, concentrates, bloodlines, and the renal pharmaceuticals Venofer and Velphoro to healthcare providers.

Product overview

Fresenius Medical Care North America offers a comprehensive, vertically integrated portfolio of dialysis products and services. The core offering includes in-center dialysis equipment (5008X CAREsystem, 2008T BlueStar Dialysis Machine) and HighVolumeHDF therapy for hemodiafiltration treatment. Home dialysis solutions include the Liberty Select Cycler, stay•safe CAPD system, and kinexus for peritoneal dialysis. The product line extends to critical care with Novalung ECMO therapy and fluid management devices including CLiC and Crit-Line IV Monitor. Supporting infrastructure includes water treatment systems (AquaA, AquaBPlus, AquaB LITE, AquaC UNO H) and dissolution systems. The consumables portfolio covers dialyzers, concentrates, and bloodlines. Renal pharmaceuticals include Venofer (iron supplementation) and Velphoro (phosphate binder). Together, these products enable the company to provide complete kidney care from in-center to home-based treatment settings.

Differentiator

Problem solved

Functional benefit

Brands

• Fresenius Kidney Care: Kidney care services brand offering dialysis treatments, vascular access care, and related services to patients.
• Fresenius Physician Solutions
• Frenova Renal Research
• Renal Research Institute
• 5008X CAREsystem
• 2008T BlueStar Dialysis Machine
• Liberty Select Cycler
• stay•safe CAPD System
• kinexus
• Crit-Line IV Monitor
• Novalung
• HighVolumeHDF Therapy
• CLiC Device

Products and services

• Fresenius Kidney Care (Dialysis Treatment Services) Outpatient and home dialysis treatment services for patients with end-stage renal disease and chronic kidney disease, delivered through the company's owned dialysis center network.
• Vascular Access Care Clinical services for the creation and maintenance of vascular access sites required for dialysis treatment in kidney patients.
• Laboratory & Diagnostic Services Laboratory and diagnostic testing services for dialysis and kidney disease patients, including routine bloodwork and treatment monitoring.
• Renal Pharmacy Services Specialized pharmacy services staffed by renal-trained pharmacists, providing medications and clinical pharmacy support to dialysis patients.
• Fresenius Physician Solutions (Practice Management) Practice management and operational support services offered to nephrologists and kidney care physician practices through the Doctors Corner portal and dedicated support teams.
• Renal Research Institute Clinical research organization dedicated to advancing kidney disease treatment and renal care through investigator-led studies.
• Frenova Renal Research Renal-focused clinical research services and trial management supporting drug development and kidney disease therapeutic research.
• Apheresis Services Therapeutic apheresis services provided to physician practices and hospitals for kidney-related and other specialty indications.
• 5008X CAREsystem In-center hemodialysis machine designed for high-volume hemodiafiltration therapy, sold to hospitals and dialysis centers.
• 2008T BlueStar Dialysis Machine In-center hemodialysis machine used by hospitals and dialysis clinics to perform hemodialysis treatments.
• HighVolumeHDF Therapy Hemodiafiltration therapy modality delivered on Fresenius in-center hemodialysis machines to provide enhanced clearance for dialysis patients.
• Liberty Select Cycler Automated peritoneal dialysis cycler for patients performing home peritoneal dialysis treatment.
• stay•safe System / CAPD Continuous Ambulatory Peritoneal Dialysis (CAPD) system used by patients for home-based peritoneal dialysis.
• kinexus Peritoneal dialysis product line for patients performing home dialysis treatment.
• CLiC Device Fluid management device used during dialysis treatment to monitor and control patient fluid levels.
• Crit-Line IV Monitor Inline hematocrit and oxygen saturation monitor providing real-time fluid management data during dialysis and critical care treatments.
• Novalung ECMO Therapy ECMO device providing extracorporeal heart and lung support for patients in critical care settings.
• AquaA Central Dialysis Water System Central water purification system for dialysis facilities, providing treated water meeting hemodialysis standards.
• AquaBPlus Water Treatment System Water treatment system for dialysis water purification in clinical settings.
• AquaB LITE Water Treatment System Compact water treatment system for dialysis water purification, suited to smaller or home-based dialysis setups.
• AquaC UNO H Water Treatment System Water treatment system designed for dialysis applications in clinical environments.
• Accumix Dissolution Systems Dissolution systems used by dialysis centers to prepare dialysate concentrates from powder formulations.
• Dialyzers Disposable dialyzer cartridges used in hemodialysis to filter blood for kidney failure patients.
• Concentrates Dialysate concentrates used to formulate the dialysis solution delivered to patients during hemodialysis treatments.
• Bloodlines Single-use blood tubing sets that connect the patient to the hemodialysis machine during treatment.
• Venofer Intravenous iron sucrose medication for the treatment of iron deficiency anemia in patients with chronic kidney disease, including those on dialysis.
• Velphoro Oral phosphate binder medication used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.

Quantifiable outcome

• More than 44 million dialysis treatments delivered in 2025

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature12 records

Partnerships

One partnership is on record.

• Allied Market ResearchminorOthersMarket research firm providing industry analysis and market projections for the kidney dialysis industry that Fresenius operates within. The partnership provides market sizing data indicating the global kidney dialysis market projected to grow from $79.6 billion in 2023 to $149.7 billion by 2033.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

Market position

Competitive moat6 records

Key highlights6 records

Customer concentration

• Xx.com/fmcnanews
• YouTubeyoutube.com/c/FreseniusMedicalCareNorthAmerica
• Facebookfacebook.com/FreseniusMedicalCareNA
• LinkedInlinkedin.com/company/freseniusmedicalcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries12 records

Funding overview

Funding rounds33 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fresenius Medical Care North America